NCT06171048View on ClinicalTrials.gov

Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Healthy
Interventions
BIOLOGICAL

CM310

CM310 injection

Trial Locations (1)

Unknown

The Second Hospital of Anhui Medical University, Hefei

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06171048 - Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects | Biotech Hunter | Biotech Hunter